With Biograph mCT Flow™1 and Symbia Intevo™1, Siemens provides physicians with a compass that helps them chart the fastest route toward health. Physicians at leading institutions are leveraging these innovations to confidently diagnose, treat and monitor disease.
Biograph mCT Flow overcomes the limitations of conventional PET/CT systems with technology that acquires data using continuous motion. This technique, called FlowMotion™, increases exam efficiency by minimizing acquisition times and reduces patient radiation dose due to over-scanning by only scanning the precise scan area desired. FlowMotion gathers a stream of data, as the patient table advances the patient continuously through the detector rings. This allows, for instance, the inclusion of the highest resolution2 scans (400x400 matrix) and respiratory gating to eliminate motion artifacts associated to breathing that can obscure signs of disease in a single continuous acquisition.
Conventional SPECT/CT is limited in its ability to deliver definitive and timely answers to clinical questions in the most effective and efficient way possible. Siemens is addressing these challenges with Symbia Intevo™*, the world’s first xSPECT1— a new modality that completely integrates SPECT and CT data during image reconstruction. Producing hybrid images of greater resolution than ever before, and—for the first time—the basis for accurate and reproducible quantitative SPECT measurements.
The higher resolution and clinical detail of xSPECT supports physicians’ ability to more confidently distinguish between degenerative disease and cancer, reducing the need for follow-up exams. The system' quantitative capabilities support physician therapy planning and early modification of patient treatment to reduce costs associated with ineffective therapies.
With Biograph mCT Flow and Symbia Intevo, together we are transforming the role of molecular imaging and patient care.
